---
title: "ZURA.US (ZURA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ZURA.US/news.md"
symbol: "ZURA.US"
name: "ZURA.US"
parent: "https://longbridge.com/en/quote/ZURA.US.md"
datetime: "2026-03-16T01:57:21.179Z"
locales:
  - [en](https://longbridge.com/en/quote/ZURA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ZURA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ZURA.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ZURA.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ZURA.US/news.md)


# ZURA.US (ZURA.US) — Related News

### [SPAC JATT II Acquisition files for a $60 million IPO, targeting biotech and life sciences](https://longbridge.com/en/news/279094138.md)
*2026-03-13T21:17:18.000Z*
> JATT II Acquisition, a SPAC focused on biotech and life sciences, has filed with the SEC for a $60 million IPO, offering

### [Zura Bio Updates Corporate Outlook on Lead Tibulizumab Program](https://longbridge.com/en/news/278540971.md)
*2026-03-10T10:59:09.000Z*
> Zura Bio Updates Corporate Outlook on Lead Tibulizumab Program

### [Zura Bio updates corporate presentation, flags tibulizumab Phase 2 readouts, cash and shares](https://longbridge.com/en/news/278538573.md)
*2026-03-10T10:43:01.000Z*
> Zura Bio has updated its corporate presentation, focusing on the development of tibulizumab, a bispecific targeting IL-1

### [Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares | ZURA Stock News](https://longbridge.com/en/news/277190447.md)
*2026-02-27T03:30:00.000Z*
> Zura Bio Limited has successfully closed its public offering of 21.2 million Class A ordinary shares and 1.8 million pre

### [Zura Bio Announces Pricing Of $125 Million Public Offering Of Class A Ordinary Shares And Pre-Funded Warrants](https://longbridge.com/en/news/276878314.md)
*2026-02-25T11:31:07.000Z*
### [BUZZ-Zura Bio falls after commencing stock offering](https://longbridge.com/en/news/276793071.md)
*2026-02-24T22:00:02.000Z*
### [12 Health Care Stocks Moving In Tuesday's After-Market Session](https://longbridge.com/en/news/276786122.md)
*2026-02-24T21:05:55.000Z*
> Inogen (NASDAQ:INGN) shares rose 10.3% to $6.44, following Q4 earnings release. BridgeBio Pharma (NASDAQ:BBIO) increased